The inhibitory effects of some antiphlogistic drugs on the glucosamine incorporation into mucopolysaccharides synthesized by fibroblast cultures.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002247:Carbon Isotopes; D003470:Culture Media; D005347:Fibroblasts / Q000378:metabolism*; D005944:Glucosamine / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology*; D008528:Mefenamic Acid / Q000494:pharmacology; D051379:Mice; D010113:Oxyphenbutazone / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D012980:Sodium Salicylate / Q000494:pharmacology*; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D002247:Carbon Isotopes; D003470:Culture Media; D006025:Glycosaminoglycans; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D005944:Glucosamine; D012980:Sodium Salicylate; D007213:Indomethacin